Cognitive Behavioural Therapy for Complicated Grief Reactions in Old Age
Launched by UNIVERSITY OF AARHUS · Jan 4, 2021
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how effective two types of Cognitive Behavioural Therapy (CBT) are for older adults dealing with complicated grief after losing a loved one. Complicated grief can lead to severe feelings of sadness, anxiety, depression, and even symptoms similar to post-traumatic stress disorder. The trial aims to find out whether individual therapy or group therapy is better at helping these individuals cope with their grief and improve their overall well-being.
To participate in this study, you need to be at least 65 years old and have lost someone close to you, like a spouse or partner, at least six months ago. You should also be experiencing significant grief-related symptoms. If you join the study, you can expect to receive either individual or group therapy sessions, which will help you process your loss and learn coping strategies. This trial is important because it will help determine the best ways to support older adults struggling with grief, ultimately leading to better treatment options in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age ≥ 65 years (older adult).
- • 2. Lost a loved one (e.g., spouse, partner) ≥ 6 months ago.
- • 3. Clinically relevant symptoms of one or more types of complicated grief reactions (i.e. symptoms of prolonged grief (PG-13 ≥ 29), depression (CESD-10 ≥ 10), anxiety (GAD-7 ≥ 10), and/or posttraumatic stress (PCL ≥ 31)).
- Exclusion Criteria:
- • 1. No clinically relevant symptoms of one or more types of complicated grief reactions (i.e. symptoms of prolonged grief, depression, anxiety and/or posttraumatic stress).
- • 2. No informed consent given.
- • 3. Insufficient Danish proficiency.
- • 4. Inability to transport oneself to the clinic.
- • 5. Severe psychopathology (e.g., schizophrenia).
- • 6. Severe cognitive impairment (e.g., Alzheimer's disease).
- • 7. Substance abuse.
- • 8. Acute suicidal ideation.
About University Of Aarhus
The University of Aarhus, a prestigious research institution located in Denmark, is dedicated to advancing medical science through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university fosters an environment that encourages cutting-edge research and the development of novel therapeutic interventions. Committed to ethical standards and patient safety, the University of Aarhus aims to contribute to the global body of medical knowledge while enhancing healthcare outcomes through rigorous scientific inquiry and evidence-based practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aarhus C, , Denmark
Patients applied
Trial Officials
Maja O'Connor, PhD
Study Director
University of Aarhus
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials